ArrowMark Colorado Holdings’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-82,000
Closed -$5.92M 305
2023
Q1
$5.92M Sell
82,000
-40,000
-33% -$3.12M 0.07% 189
2022
Q4
$10M Sell
122,000
-173,000
-59% -$14.3M 0.12% 146
2022
Q3
$23.1M Hold
295,000
0.28% 96
2022
Q2
$20M Sell
295,000
-20,000
-6% -$1.4M 0.23% 105
2022
Q1
$20.6M Buy
315,000
+35,000
+13% +$2.03M 0.18% 118
2021
Q4
$17M Hold
280,000
0.14% 134
2021
Q3
$17.9M Sell
280,000
-85,000
-23% -$5.37M 0.14% 135
2021
Q2
$22.9M Hold
365,000
0.17% 125
2021
Q1
$20.9M Sell
365,000
-13,000
-3% -$703K 0.16% 127
2020
Q4
$19M Sell
378,000
-69,000
-15% -$2.75M 0.15% 129
2020
Q3
$13.2M Buy
447,000
+33,000
+8% +$958K 0.13% 125
2020
Q2
$10.4M Buy
414,000
+150,000
+57% +$3.74M 0.11% 142
2020
Q1
$4.84M Buy
+264,000
New +$7.56M 0.06% 175

Other funds holding ACHC

ArrowMark Colorado Holdings's ACHC Position: Q2 2023 in Review

ArrowMark Colorado Holdings sold out of Acadia Healthcare (ACHC) in Q2 2023, closing a stake of 82,000 shares — an estimated $5.92M sold.

ArrowMark Colorado Holdings first reported a position in ACHC in Q1 2020 and held it in 13 quarters. The position peaked at $23.1M in Q3 2022. 280 funds tracked by Wall St. Rank hold ACHC as of Q2 2023.

  • ArrowMark Colorado Holdings reported no remaining Acadia Healthcare position as of Q2 2023 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 82,000 Acadia Healthcare shares in Q2 2023, an estimated $5.92M.
  • ArrowMark Colorado Holdings first reported a position in Acadia Healthcare in Q1 2020 and held it in 13 quarters.
  • ArrowMark Colorado Holdings's Acadia Healthcare position peaked at $23.1M in Q3 2022.
  • 280 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2023.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.